Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Lung Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Disease 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Restraint, Physical 1Procalcitonin 1Polymerase Chain Reaction 1Liquid Biopsy 1In Situ Hybridization 1Immunohistochemistry 1Gene-Eden-VIR 1Gastrectomy 1Flow Cytometry 1Cytogenetic Analysis 1Blotting, Western 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Epstein-Barr Virus Infections × In Situ Hybridization × Clear all
NCT01490801 2016-05-17

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Children's Oncology Group

Completed
50 enrolled
LymphoidMyeloid

Hodgkin Disease, Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡